Skip navigation

Effectively Manage IP, Liability and Data Considerations to Expedite Trial Agreements

December 5-6, 2017
  • Philadelphia, PA

CBI’s Clinical Trial Legal and Contracting Forum serves as the only meeting that is singularly focused on the detailed legal and contracting issues that relate to clinical agreements of all types. This go-to event provides legal, compliance, contracting and operations professionals with the insights they need to construct agreements that fully address liability provisions, IP, proprietary data, confidentiality, regulations, publication requirements and much more. Through didactic presentations and interactive discussions, participants walk away with a detailed understanding of how they can work with all stakeholders (sponsors, CROs, AMCs, sites, etc.) to streamline and improve the contracting process.

Collaborate on Legal and Contracting Issues Related to Clinical Trial Agreements of All Types:

  • Examine the beginnings of human subject protection and the origins of the Common Rule
  • Explore considerations for mitigating risk in trial agreements
  • Review the legal and regulatory obligations around the collection, sharing and storage of research participant data
  • Learn ways to approach negotiations and speed up site activation
  • Understand key considerations and challenges in Clinical Research Collaborations (CRCs)
  • Best practices for developing trial agreements

Previous CTA Series Attendee Acclaim:

Great topics and speakers! I love that this is small — makes networking possible, and the 2 day timeline is great!

Project Representative, University of Michigan

The roundtable discussions were invaluable — it was enriching to hear challenges faced by sites, CROs, and sponsors.

Regulatory and Finance Coordinator, West Michigan Clinical Research Center

This was enjoyable and valuable.

VP of Contracting, Clinical Research Management

Great information. It’s interesting to see problems from sponsor/CRO/site perspectives that you wouldn’t get normally.

Lead Contract Coordinator, Elias Research Associates

I was excited to see both CLEAR and ACTA discussed
in an open stakeholder forum.

VP, Site Services, Quintiles